SIFI PRESENTS ITS NEW PRODUCTS AND SCIENTIFIC DATA AT THE 42ND EUROPEAN ASSOCIATION OF CATARACT AND REFRACTIVE SURGERY CONGRESS

(MENAFN– PR Newswire) CATANIA, Italy, Sept. 6, 2024 /PRNewswire/ — SIFI, a leading international ophthalmic company, is pleased to announce that it will present two product innovations and new scientific data at the upcoming trade fair. congress
European Society of Cataract and Refractive Surgeons (ESCRS)
Taking place from September 6-10 Barcelona (Spain).

“SIFI is leading the way in wavefront integration technology “With ocular surface management technologies to advance the standard of care in refractive cataract surgery. By customizing intraocular lens optics and ocular surface treatments, our solutions enable patients to achieve superior vision quality,” said Maria Cristina Curatolo, SIFI’s Innovation and Medical Sciences Manager.

Two new products will be introduced:

A new version
EVOLUX extended monofocal intraocular lens (IOL), which provides smoother application with improved injection technology and the freedom to choose between push or screw technique;

A new
The IOL calculator, based on the Hoffer QST and Næser-Savini formulas, enables more precise calculations of spherical and cylindrical powers thanks to the use of artificial intelligence.

A total of five podium presentations and five ePosters will present clinical results from SIFI’s cataract refractive surgery and ocular surface disease solutions, including EVOLUX, the presbyopia-correcting WELL FUSION system, and the artificial tear Eyestil SYNFO. The schedule of scientific presentations is as follows:

Posters will be presented on Sunday, September 8th (14:15-15:45 | Room: Halls 6 and 7 – Pod 1)

The Impact of a New Extended Lifestyle on Visual Performance, Subjective Satisfaction, and Quality of Life
Monofocal Intraocular Lens (IOL) (Pagnacco C.);

Multicenter Clinical Trial on the Use of Preservative-Free Ophthalmic Solution Based on Sodium Hyaluronate, Osmoprotectants, and Xanthan Gum in the Treatment of Eye Conditions, Especially Dry Eye (Molero-Senosiain M.);

Visual and Refractive Outcomes After Extended Lens Implantation
Monofocal Non-Diffractive Hydrophobic Intraocular Lens (Romualdi G.);

Comparison of intermediate visual acuity of the two eyes
Improved non-diffraction monofocal intraocular lenses (Rotter A.).

Tuesday 10th Free Paper Session (11:00-12:30 | Room: Free paper podium 1)

Impact of Visual Performance, Subjective Satisfaction, and Quality of Life After Dual Implantation of Extended Depth of Focus
Intraocular Lens (Edoph IOL) Compared with Trifocal IOL: A Randomized Clinical Trial (Pagnacco C.).

On Monday, September 9th (13.00-14.00 – Room 8.10) SIFI will be holding a conference. Satellite Symposium “Ultimate Vision: Mastering Vision with Wavefront Engineering and Innovative Eye Surface Management”
We present clinical updates by Dr. G. Savini, Prof. O. Findl, Dr. K. Gabric, Prof. E. Pedrotti and Prof. R. Mencucci.

E-Poster list includes:

Functional results of a newly developed system
monofocal IOL (Savini G. – poster ID PO323)

Long-Term Visual Results
Monofocal Intraocular Lens (EVOLUX®) After Cataract Surgery (Caparas V. – poster ID PO347)

Visual Performance of a New Advanced
Monofocal Iol – Sifi Evolux (Gabric K. – poster ID PO330)

Assessment of Binocular Vision and Subjective
Photic Disorders After Intraocular Lens Implantation Between the Sifi Well Fusion Edof System and Three Trifocal IOLs (Physiol Finevision, Alcon Clareon Panoptix and Ast Asqelio Trifocal) (Castanera D. – poster ID PO574)

Predictive Visual Acuity and Clinical Validation Based on Wavefront Engineering Technology for Three IOLs (Vacalebre M. – poster ID PO592)

ABOUT SIFI:
SIFI is a leading international ophthalmic company headquartered in Italy with an integrated business model from research and development to manufacturing and commercialization in both the pharmaceutical and biomedical sectors. Since our founding in 1935, our mission has been to improve people’s lives through meaningful innovations in eye care. SIFI exports to over 40 countries worldwide, with a direct presence in major European markets, Mexico, and through joint ventures in China and the United Arab Emirates. For more information, see: